Photo from wikipedia
We show that spironolactone use was associated with an increased rate of all-cause hospitalizations, but no difference in hospitalizations for heart failure or pulmonary arterial hypertension, in patients with World… Click to show full abstract
We show that spironolactone use was associated with an increased rate of all-cause hospitalizations, but no difference in hospitalizations for heart failure or pulmonary arterial hypertension, in patients with World Health Organization Group 1 pulmonary arterial hypertension. A possible reason for this finding is confounding from retrospective study design.
Keywords:
arterial hypertension;
pulmonary arterial;
hospitalization associated;
associated use;
rates hospitalization
Journal Title: Pulmonary Circulation
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pulmonary Circulation
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!